Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)
American pharmaceutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the pharmaceutical industry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed to halve the time required to identify ...continuare.
EMAG
sa 6 cifrã promising chiftelute the space ruta klasse oara osta edmond misi herman darth vader niri regiona curat nunti anei emeric tuti drama incepe scoala se inchide salazar strategi realitate la regi renovate hotarare cand a loç fc botosani blogger merced snppc dantela ia par partidul verde piata auto combinatul danci doliu national rain cerc da 12 jonathan utilizare orman rector fund



© Copyright 2000-2026 iStorm. Toate drepturile rezervate.